Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.

Added 504 days ago (09.01.2021)
Authors: Brum MCM, Dos Santos Guimaraes I, Ferreira LB, Rangel LBA, Maia RC, Nestal De Moraes G, Gimba ERP
PubMed id: 33416171
Read article